Scientific and Medical Equipment House Company (TADAWUL:4014)
Saudi Arabia
· Delayed Price · Currency is SAR 33.88
+1.38 (4.25%)
Dec 4, 2025, 3:10 PM AST
TADAWUL:4014 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 922.02 | 877.23 | 776.67 | 713.82 | 699.45 | 617.47 | Upgrade
|
| Revenue Growth (YoY) | 4.78% | 12.95% | 8.80% | 2.05% | 13.28% | 3.43% | Upgrade
|
| Cost of Revenue | 794.81 | 744.07 | 647.92 | 560.04 | 546.7 | 467.03 | Upgrade
|
| Gross Profit | 127.2 | 133.16 | 128.75 | 153.78 | 152.75 | 150.45 | Upgrade
|
| Selling, General & Admin | 85.39 | 82.9 | 75.69 | 78.18 | 65.89 | 63.62 | Upgrade
|
| Operating Expenses | 87.19 | 78.33 | 54.18 | 117.61 | 70.36 | 63.62 | Upgrade
|
| Operating Income | 40.01 | 54.83 | 74.56 | 36.17 | 82.39 | 86.83 | Upgrade
|
| Interest Expense | -16.51 | -25.32 | -24.91 | -19.65 | -12.95 | -12.55 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.05 | 0.33 | 0.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.78 | 16.3 | 12.5 | 11.08 | 14.84 | 6.69 | Upgrade
|
| EBT Excluding Unusual Items | 37.27 | 45.8 | 62.15 | 27.65 | 84.62 | 81.32 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.15 | 0.09 | 0.01 | 0.09 | 0.22 | 0.23 | Upgrade
|
| Pretax Income | 38.58 | 45.89 | 62.16 | 27.74 | 84.83 | 81.55 | Upgrade
|
| Income Tax Expense | 15.96 | 14.65 | 15.14 | 12.12 | 8.09 | 7.39 | Upgrade
|
| Earnings From Continuing Operations | 22.63 | 31.23 | 47.02 | 15.62 | 76.75 | 74.16 | Upgrade
|
| Earnings From Discontinued Operations | 1.37 | -6.63 | -9.22 | - | - | - | Upgrade
|
| Net Income to Company | 24 | 24.61 | 37.8 | 15.62 | 76.75 | 74.16 | Upgrade
|
| Minority Interest in Earnings | 2.56 | 1.56 | 2.26 | 1.95 | 0.78 | 0.6 | Upgrade
|
| Net Income | 26.56 | 26.17 | 40.06 | 17.57 | 77.52 | 74.76 | Upgrade
|
| Net Income to Common | 26.56 | 26.17 | 40.06 | 17.57 | 77.52 | 74.76 | Upgrade
|
| Net Income Growth | -35.11% | -34.67% | 128.04% | -77.34% | 3.70% | 5.79% | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| EPS (Basic) | 0.89 | 0.87 | 1.34 | 0.59 | 2.58 | 2.49 | Upgrade
|
| EPS (Diluted) | 0.89 | 0.87 | 1.34 | 0.59 | 2.58 | 2.49 | Upgrade
|
| EPS Growth | -35.11% | -34.67% | 128.04% | -77.34% | 3.70% | 5.79% | Upgrade
|
| Free Cash Flow | 31.36 | 281.35 | -155.51 | 133.46 | -79.49 | 94.34 | Upgrade
|
| Free Cash Flow Per Share | 1.04 | 9.38 | -5.18 | 4.45 | -2.65 | 3.15 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 1.000 | - | 0.667 | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | - | -33.33% | - | Upgrade
|
| Gross Margin | 13.80% | 15.18% | 16.58% | 21.54% | 21.84% | 24.37% | Upgrade
|
| Operating Margin | 4.34% | 6.25% | 9.60% | 5.07% | 11.78% | 14.06% | Upgrade
|
| Profit Margin | 2.88% | 2.98% | 5.16% | 2.46% | 11.08% | 12.11% | Upgrade
|
| Free Cash Flow Margin | 3.40% | 32.07% | -20.02% | 18.70% | -11.36% | 15.28% | Upgrade
|
| EBITDA | 49.39 | 64.9 | 85.87 | 47.73 | 91.47 | 93.14 | Upgrade
|
| EBITDA Margin | 5.36% | 7.40% | 11.06% | 6.69% | 13.08% | 15.08% | Upgrade
|
| D&A For EBITDA | 9.38 | 10.07 | 11.31 | 11.56 | 9.08 | 6.31 | Upgrade
|
| EBIT | 40.01 | 54.83 | 74.56 | 36.17 | 82.39 | 86.83 | Upgrade
|
| EBIT Margin | 4.34% | 6.25% | 9.60% | 5.07% | 11.78% | 14.06% | Upgrade
|
| Effective Tax Rate | 41.35% | 31.94% | 24.35% | 43.70% | 9.53% | 9.07% | Upgrade
|
| Advertising Expenses | - | 0.03 | 0.01 | 0.27 | 0.22 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.